Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friedrich E Kruse

Showing results (1-10 of 197) with videos related to

Pageof 20
Sort By:
Investigative Ophthalmology & Visual Science|January 5, 2002
Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathwayLingtao You, Friedrich E Kruse
Medizinische Monatsschrift Fur Pharmazeuten|July 3, 2004
[Treatment of "dry eyes"]Alexander F Scheuerle, Friedrich E Kruse
Experimental Eye Research|July 30, 2005
Identification and characterization of limbal stem cellsUrsula Schlötzer-Schrehardt, Friedrich E Kruse
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 21, 2012
Prospective, randomized, controlled comparison of SYSTANE UD eye drops versus VISINE INTENSIV 1% EDO eye drops for the treatment of moderate dry eyeChristina Jacobi, Friedrich E Kruse, Claus Cursiefen
American Journal of Ophthalmology|June 16, 2026
Descemet Stripping Only in Fuchs Endothelial Corneal Dystrophy: Results of a Randomized Clinical Trial of Topical Ripasudil and Directions for Future InnovationKathryn Colby, Friedrich E Kruse, Shigeru Kinoshita
Current Opinion in Ophthalmology|May 30, 2014
Optimizing outcomes with Descemet's membrane endothelial keratoplastyFriedrich E Kruse, Ursula Schlötzer Schrehardt, Theofilos Tourtas
Cornea|September 4, 2021
A Close Look at the Clinical Efficacy of Rho-Associated Protein Kinase Inhibitor Eye Drops for Fuchs Endothelial Corneal DystrophyShigeru Kinoshita, Kathryn A Colby, Friedrich E Kruse
Cornea|June 4, 2008
Persisting corneal erosion under cetuximab (Erbitux) treatment (epidermal growth factor receptor antibody)Claudia G Foerster, Claus Cursiefen, Friedrich E Kruse
American Journal of Ophthalmology Case Reports|September 24, 2024
Keratomalacia and corneal perforation in vitamin A deficiency: Anterior-segment optical-coherence-tomography and histological findingsJulia M Weller, Theofilos Tourtas, Friedrich E Kruse
International Ophthalmology|January 9, 2022
Descemet membrane endothelial keratoplasty: analysis of clinical outcomes of patients with 8-10 years follow-upJulia M Weller, Friedrich E Kruse, Theofilos Tourtas
Pageof 20

Showing results (1-10 of 197) with videos related to

Sort By:
Pageof 20
Investigative Ophthalmology & Visual Science|January 5, 2002
Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathwayLingtao You, Friedrich E Kruse
Medizinische Monatsschrift Fur Pharmazeuten|July 3, 2004
[Treatment of "dry eyes"]Alexander F Scheuerle, Friedrich E Kruse
Experimental Eye Research|July 30, 2005
Identification and characterization of limbal stem cellsUrsula Schlötzer-Schrehardt, Friedrich E Kruse
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|July 21, 2012
Prospective, randomized, controlled comparison of SYSTANE UD eye drops versus VISINE INTENSIV 1% EDO eye drops for the treatment of moderate dry eyeChristina Jacobi, Friedrich E Kruse, Claus Cursiefen
American Journal of Ophthalmology|June 16, 2026
Descemet Stripping Only in Fuchs Endothelial Corneal Dystrophy: Results of a Randomized Clinical Trial of Topical Ripasudil and Directions for Future InnovationKathryn Colby, Friedrich E Kruse, Shigeru Kinoshita
Current Opinion in Ophthalmology|May 30, 2014
Optimizing outcomes with Descemet's membrane endothelial keratoplastyFriedrich E Kruse, Ursula Schlötzer Schrehardt, Theofilos Tourtas
Cornea|September 4, 2021
A Close Look at the Clinical Efficacy of Rho-Associated Protein Kinase Inhibitor Eye Drops for Fuchs Endothelial Corneal DystrophyShigeru Kinoshita, Kathryn A Colby, Friedrich E Kruse
Cornea|June 4, 2008
Persisting corneal erosion under cetuximab (Erbitux) treatment (epidermal growth factor receptor antibody)Claudia G Foerster, Claus Cursiefen, Friedrich E Kruse
American Journal of Ophthalmology Case Reports|September 24, 2024
Keratomalacia and corneal perforation in vitamin A deficiency: Anterior-segment optical-coherence-tomography and histological findingsJulia M Weller, Theofilos Tourtas, Friedrich E Kruse
International Ophthalmology|January 9, 2022
Descemet membrane endothelial keratoplasty: analysis of clinical outcomes of patients with 8-10 years follow-upJulia M Weller, Friedrich E Kruse, Theofilos Tourtas
Pageof 20